Literature DB >> 2847391

Bovine leukaemia: facts and hypotheses derived from the study of an infectious cancer.

A Burny1, Y Cleuter, R Kettmann, M Mammerickx, G Marbaix, D Portetelle, A van den Broeke, L Willems, R Thomas.   

Abstract

Bovine leukaemia virus (BLV) is the etiological agent of chronic lymphatic leukaemia/lymphoma in cows, sheep and goats. Infection without neoplastic transformation was also obtained in pigs, rhesus monkeys, chimpanzees, rabbits and observed in capybaras and water-buffaloes. Structurally and functionally, BLV is a relative of human T lymphotropic viruses 1 and 2 (HTLV-I and HTLV-II) In humans, HTLV-I induces a T-cell leukaemia and its type 2 counterpart has been found in dermatopathic lymphadenopathy, hairy T-cell leukaemia and prolymphocytic leukaemia cases. At variance with HTLV-I, BLV has not been associated with neurological diseases of the degenerative type. Bovine leukaemia virus, HTLV-I and HTLV-II show clearcut sequence homologies. The pathology of the BLV-induced disease, most notably the absence of chronic viraemia, a long latency period and lack of preferred proviral integration sites in tumours, is similar to that of adult T-cell leukaemia/lymphoma induced by HTLV-I. The most striking feature of these three naturally transmitted leukaemia viruses is the X region located between the env gene and the long terminal repeat (LTR) sequence. The X region contains several overlapping long open reading frames. One of them, designated XBL-I, encodes a trans-activator function capable of increasing the level of gene expression directed by BLV-LTR and most probably is involved in "genetic instability" of BLV-infected cells of the B cell lineage. The "genetic instability" renders the infected cell susceptible to move, along a number of stages, towards full malignancy. Little is known about these events and their causes; we present some theoretical possibilities. Bovine leukaemia virus infection has a worldwide distribution. In temperate climates, the virus spreads mostly via iatrogenic transfer of infected lymphocytes. In warm climates and in areas heavily populated by haematophagous insects, there are indications of insect-borne propagation of the virus.

Entities:  

Mesh:

Year:  1988        PMID: 2847391     DOI: 10.1016/0378-1135(88)90066-1

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  38 in total

1.  Interaction between Bovine leukemia virus (BLV) infection and age on telomerase misregulation.

Authors:  Farhid Hemmatzadeh; Hadi Keyvanfar; Noor Haliza Hasan; Faustina Niap; Ebrahim Bani Hassan; Azar Hematzade; Esmaeil Ebrahimie; Andrea McWhorter; Jagoda Ignjatovic
Journal:  Vet Res Commun       Date:  2015-02-11       Impact factor: 2.459

2.  Fusion of bovine leukemia virus with target cells monitored by R18 fluorescence and PCR assays.

Authors:  S Zarkik; F Defrise-Quertain; D Portetelle; A Burny; J M Ruysschaert
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

3.  T-cell lymphoma lines derived from rat thymomas induced by Moloney murine leukemia virus: phenotypic diversity and its implications.

Authors:  P A Lazo; A J Klein-Szanto; P N Tsichlis
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

4.  Molecular characterization of the env gene from Brazilian field isolates of Bovine leukemia virus.

Authors:  Marcelo Fernandes Camargos; Ariel Pereda; Daniel Stancek; Maurílio Andrade Rocha; Jenner Karlisson Pimenta dos Reis; Irene Greiser-Wilke; Rômulo Cerqueira Leite
Journal:  Virus Genes       Date:  2006-08-18       Impact factor: 2.332

5.  Religiosity and Beliefs About the Transmission of Cancer, Chemotherapy, and Radiation Through Physical Contact in Saudi Arabia.

Authors:  Rolina Al-Wassia; Faten Al-Zaben; Mohammad Gamal Sehlo; Harold G Koenig
Journal:  J Relig Health       Date:  2019-02

6.  Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70.

Authors:  M H Gatei; H M Naif; S Kumar; D B Boyle; R C Daniel; M F Good; M F Lavin
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

7.  Episodic occurrence of antibodies against the bovine leukemia virus Rex protein during the course of infection in sheep.

Authors:  M A Powers; D Grossman; L C Kidd; K Radke
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

8.  Activation of bovine leukemia virus transcription in lymphocytes from infected sheep: rapid transition through early to late gene expression.

Authors:  M A Powers; K Radke
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

9.  Identification of alternatively spliced mRNAs encoding potential new regulatory proteins in cattle infected with bovine leukemia virus.

Authors:  S Alexandersen; S Carpenter; J Christensen; T Storgaard; B Viuff; Y Wannemuehler; J Belousov; J A Roth
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

10.  Reduced levels of reactive oxygen species correlate with inhibition of apoptosis, rise in thioredoxin expression and increased bovine leukemia virus proviral loads.

Authors:  Amel Baya Bouzar; Mathieu Boxus; Arnaud Florins; Carole François; Michal Reichert; Luc Willems
Journal:  Retrovirology       Date:  2009-11-10       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.